资讯

Navigating the complexities of the pharmaceutical industry, from innovator economics to generics, CRDMO, and biosimilars for ...
The success of pharmaceutical companies in developing drugs for treating and curing medical conditions is largely dependent ...
Behind the scenes, major pharmaceutical companies and Trump-tied billionaires are furiously lobbying in opposite directions ...
The Drug Discovery Outsourcing Market is set to grow at a 7.2% CAGR, driven by advanced technologies and increased demand for specialized expertise. NEWARK, DE, UNITED STATES, September 11, 2025 ...
Zacks Investment Research on MSN3 天Opinion

5 Large Drug Stocks to Watch Despite Industry & Macro Headwinds

The drug and biotech sector is facing multiple headwinds. President Trump has warned of heavy tariffs, as high as 250%, on ...
It's not the first time this year the popular drug's manufacturer has faced issues. Check to see if your prescription is ...
Health Secretary Robert F. Kennedy Jr. and other administration officials are vowing to crack down on deceptive drug ads, but ...
Vertex Pharmaceuticals is backed by CF dominance and JOURNAVX optionality, with key catalysts ahead for growth and upside.
Today, Zacks Equity Research discusses Eli Lilly LLY, Johnson & Johnson JNJ, Novartis NVS, Pfizer PFE and Bayer BAYRY.
Amneal is a pharma brand with a diverse and growing drug portfolio, strong cash flow metrics, and an improving debt situation ...